As fibroblasts secrete C7 protein, the major component of dermal anchoring fibrils, intradermal injection of fibroblasts is, therefore, a relatively straightforward gene therapy approach for RDEB patients with the absence of C7 expression.5 The gene discussed is C7; the disease is recessive dystrophic epidermolysis bullosa.